Author
A. J. Levine
University of California, Los Angeles
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2024 · peak 1/yrCo-Author Collaboration Network
10 top collaborators · 17 mutual co-author links5 papers
Recent·Most cited
Universal DNA methylation age across mammalian tissues
Ake Tzu-Hui Lu, Zhe Fei, Amin Haghani, Todd R. Robeck, Joseph Alan Zoller, Caesar Z. Li, Robert Lowe, Qi Jiang Yan, Joshua Zhang, H. Vu, Julia Ablaeva, Victoria A. Acosta-Rodríguez, Danielle M. Adams, Javier Almunia, Ajoy Aloysius, , June Mergl
The paper develops universal epigenetic clocks that accurately estimate age across mammalian tissues using DNA methylation data from 185 species.
Nature Aging · Aug 10, 2023Peer-reviewedDevelopmental Biology
Geometric Network Analysis Provides Prognostic Information in Patients with High Grade Serous Carcinoma of the Ovary Treated with Immune Checkpoint Inhibitors
R. Elkin, J. H. Oh, Y. L. Liu, P. Selenica, B. Weigelt, J. S. Reis-Filho, D. Zamarin, J. O. Deasy, L. Norton, A. J. Levine, A. R. Tannenbaum
This paper introduces a network curvature-based method to predict prognosis in high-grade serous ovarian cancer patients treated with immune checkpoint inhibitors using copy number alterations.
bioRxiv · Jun 10, 2021Cancer Biology
Identification of Relevant Genetic Alterations in Cancer using Topological Data Analysis
R. Rabadan, Y. Mohamedi, U. Rubin, T. Chu, O. Elliott, L. Arnes, S. Cal, A. J. Obaya, A. J. Levine, P. G. Camara
This study identifies 38 candidate cancer-associated genes using topological data analysis integrated with somatic mutations and RNA expression data across 12 tumor types.
bioRxiv · Jan 30, 2020Cancer Biology
Robust and Interpretable PAM50 Reclassification Exhibits Survival Advantage for Myoepithelial and Immune Phenotypes
J. Mathews, S. Nadeem, A. J. Levine, M. Pouryahya, J. O. Deasy, A. Tannenbaum
The paper reclassifies breast tumors into 7 classes using interpretable mRNA signatures, showing improved survival outcomes for myoepithelial and immune-related phenotypes.
bioRxiv · Jul 16, 2019Cancer Biology